Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2008-05-13
2008-05-13
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Vector, per se
C424S199100
Reexamination Certificate
active
07371572
ABSTRACT:
The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and prophylactics, which concern chimeric or conjugated virus-like particles, and methods of use of the foregoing are provided for the study of B cell tolerance and the treatment or prevention of human diseases, which involve the onset of B cell tolerance, such as chronic viral infection, chronic inflammatory disease, and neoplasia.
REFERENCES:
patent: 5143726 (1992-09-01), Thornton et al.
patent: 5437951 (1995-08-01), Lowy et al.
patent: 5618536 (1997-04-01), Lowy et al.
patent: 5698424 (1997-12-01), Mastico et al.
patent: 5723287 (1998-03-01), Russell et al.
patent: 6719978 (2004-04-01), Schiller et al.
patent: 684782 (1994-12-01), None
patent: 0 385 610 (1994-03-01), None
patent: 752886 (1998-01-01), None
patent: WO 9929723 (1999-06-01), None
patent: WO 0032227 (2000-06-01), None
Backer et al. Micro. Mole. Biol. Rev. 1999, vol. 63, No. 4, pp. 862-922.
Zeng et al. J. Virol. 1998, vol. 72, No. 1, pp. 201-208.
Neiland et al. J. Cell. Biochem. May 1999, vol. 73, pp. 145-152.
Kirnbauer et al. Proc. Natl. Acad. Sci. U.S.A. 1992, vol.89, pp. 12180-12184.
Baker et al. Biophys J. Dec. 1991;60 (6):1445-1456.
Baker et al. Micro. Mole. Biol. Retro. 1999, vol. 63, No. 4, pp. 862-922.
Olson et al. (J. Virol. 1999, vol. 73, No. 5, pp. 4145-4155.
Altin et al. Analytical Biochemistry 1995, vol. 224, pp. 382-389.
Vasiljeva, I., et al. (1998) “Mosaic Qβ Coats as a New Presentation Model.”FEBS Lett.431:7-11.
Adams, S.E. (1993) “Induction of humoral and cellular immunity by recombinant, particulate antigen presentation systems,” Database Embase, Accession No. EMB-1994076722, XP002367358.
Chang. C. et al. (1994) “Phenotypic mixing between different hepadnavirus nucleocapsid proteins reveals C protein dimerization to becispreferential.”Journal of Virology, 68:5225-5231.
Aichele, P., et al. (1994) peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model.PNAS USA91:444-448.
Albert, L.J., et al. (1999) Molecular Mimicry and Autoimmunity.N Engl. J. Med.341:2068-2074.
Alkhatib, G., et al. (1996) CC CKR5: A Rantes, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1.Science272:1955-1958.
Alkhatib, G., et al. (1997) CC Chemokine Receptor 5-Mediated Signaling and HIV-1 Co-receptor Activity Share Common Structural Determinants.J. Biol. Chem.272:19771-19776.
Atchinson, R.E., et al. (1996) Multiple Extracellular Elements of CCR5 and HIV-1 Entry: Dissociation from Response to Chemokines.Science274:1924-1926.
Bachmann, M.F., et al. (1993) The Influence of Antigen Organization on B Cell Responsiveness.Science262:1448-1451.
Bachmann, M.F., et al. (1996) The influence of virus structure on antibody responses and virus serotype formation.Immunol. Today17:553-558.
Bachmann, M.F., et al. (1997) Neutralizing Antiviral B Cell Responses.Annu. Rev. Immunol.15:235-270.
Bachmann, M.F., et al. (1997) The Role of Antibody Concentration and Avidity in Antiviral Protection.Science276:2024-2027.
Baker, T.S., et al. (1991) Structures of bovine and human papillomaviruses Analysis by cryoelectron microscopy and three-dimensional image reconstruction.Biophys. J.60:1445-1456.
Baselga, J., et al. (1996) Phase II Study of Weekly Intravenous Recombinant Humanized Anti-p185HER2Monoclonal Antibody in Patients with HER2
eu-Overexpressing Metastatic Breast Cancer.J. Clin. Oncol.14:737-744.
Bloom, J.W., et al. (1993) Epitope Mapping and Functional Analysis of Three Murine lgG1 Monoclonal Antibodies to Human Tumor Necrosis Factor-α.J. Immunol.151:2707-2716.
Booy, F.P., et al. (1998) Two Antibodies that Neutralize Papillomavirus by Different Mechanisms Show Distinct Binding Patterns at 13 Å Resolution.J. Mol. Biol.281:95-106.
Boring, L., et al. (1996) Molecular Cloning and Functional Expression of Murine JE (Monocyte Chemoattractant Protein 1) and Murine Macrophage Inflammatory Protein 1α Receptors.J. Biol. Chem.271:7551-7558.
Chackerian, B., et al. (1999) Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles.PNAS USA96:2373-2378.
Chackerian, B., et al. (2001) Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies,J. Clin. Invest.108:415-423.
Chang, T.W. (2000) The pharmacological basis of anti-IgE therapy.Nat. Biotechnol.18:157-162.
Choe, H., et al. (1996) The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates.Cell85:1135-1148.
Chu, R.S., et al. (1997) CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity.J. Exp. Med.186:1623-1631.
Ciapponi, L., et al. (1997) Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist.Nat. Biotechnol.13:997-1001.
Conry, R. M., et al. (Mar. 1995) Breaking tolerance to carcinoembryonic antigen with a recombinant vaccinia virus vaccine in man.Proceedings of the American Association for Cancer Research.36:492 (Abstract 2930).
Dalum, I., et al. (1996) Breaking of B Cell Tolerance Toward a Highly Conserved self ProteinJ. Immunol.157:4796-4804.
Dalum, I., et al. (1997) Induction of Cross-reactive Antibodies Against a Self Protein by Immunization with a Modified Self Protein Containing a Foreign T Helper Epitope.Mol. Immunol.34:1113-1120.
Dalum, I., et al. (1999) Therapeutic antibodies elicited by immunization against TNF-αNat. Biotechnol.17:666-669.
Deng, H., et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1.Nature381:661-666.
Doranz, B.J., et al. (1996) A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors.Cell85:1149-1158.
Dragic, T., et al. (1996) HIV-1 entry into CD4+cells is mediated by the chemokine receptor CC-CKR-5.Nature381:667-673.
Eck, M.J., et al. (1989) The Structure of Tumor Necrosis Factor-+ at 2.6 Å Resolution. J. Biol. Chem. 264:17595-17605.
Eigler, A., et al. (1997) Taming TNF: strategies to restrain this proinflammatory cytokine.Immunol. Today18:487-492.
Fehr, T., et al. (1997) Role of Repetitive Antigen Patterns for Induction of Antibodies Against Antibodies,J. Exp. Med.185:1785-1792.
Fitchen, J., et al. (1995) Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response.Vaccine13:1051-1057.
Green, N.M. (1965) A Spectrophotmetric Assay for Avidin and Biotin Based on Binding of Dyes by Avidin.Biochem. J.94:23c-24c.
Greenstone, H.L., et al. (1998) Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.PNAS USA95:1800-1805.
Han, S., et al. (1997) V(D)J Recombinase Activity in a Subset of Germinal Center B Lymphocytes.Science278:301-305.
Harro, C.D., et al. (2001) Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine.J. Natl. Cancer Inst.93:284-292.
Hedman, K., et al. (1988) Recent Rubella Virus Infection Indicated by a Low Avidity of Specific IgG.J. Clin. Immunol.8:214-221.
Herkel, J., et al. (1997) Humoral Mechanisms in T cell Vaccination: Induction and Functional Characterization of Anti-lymphocytic Autoantibodies.J. Autoimmunity10:137-146.
Hertz, M., et al. (1998) Receptor editing and commitment in B lymphocytes.Curr. Opin. Immunol.10:208-213.
Hertz, M., et al. (1998) V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling.Nature394:292-295.
Ho. S.N., et al. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction,Gene77, 51-59.
Karlsen, A.E. and Dyrberg, T. (1998) Molecular mimicry between non-self, modified self and self in autoimmunity.Semin. Immunol.10:25-34.
Kim, S.K., et al. (2001) Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3
Chackerian Bryce
Lowy Douglas R.
Schiller John T.
Campell Bruce R.
Knobbe Martens Olson & Bear LLP
Li Bao Qun
The United States of America as represented by the Department of
LandOfFree
Mouse titers after two immunizations with VLPs alone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mouse titers after two immunizations with VLPs alone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mouse titers after two immunizations with VLPs alone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2799434